Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Adma Biologics, Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Biological Products, (No Diagnostic Substances)
Prev close 8.60 · gapped above the open, never looked back. High/low 9.17 at 5:30 am ET, 8.60 at 3:45 pm ET.
Adma Biologics, Inc. has 4 disclosed suppliers and 4 disclosed customers. Each one is named in an SEC filing, either Adma Biologics, Inc.’s own annual report or the counterparty’s, and carries the sentence that discloses it.
Sources
sec edgar · verbatim disclosureEach tie, with the sentence that disclosed it. Open a row for the wording and the filing it came from.
“For the years ended December 31, 2025 and 2024, two customers, BioCare, Inc. ("BioCare") and Priority Healthcare Distribution, Inc. d/b/a CuraScript SD Specialty Distribution ("CuraScript"), represented an aggregate of approximately 73% and 72%, respectively, of our consolidated revenues.”
$186M relationship
basisADMA fy2025 · closed 2025-12 $510M
FILING10-K0001140361-26-006815cik 0001368514
“For the years ended December 31, 2025 and 2024, two customers, BioCare, Inc. ("BioCare") and Priority Healthcare Distribution, Inc. d/b/a CuraScript SD Specialty Distribution ("CuraScript"), represented an aggregate of approximately 73% and 72%, respectively, of our consolidated revenues.”
$186M relationship
basisADMA fy2025 · closed 2025-12 $510M
FILING10-K0001140361-26-006815cik 0001368514
“For the year ended December 31, 2025, two customers, BioCare, Inc. ("BioCare") and Priority Healthcare Distribution, Inc. ("CuraScript"), represented an aggregate of approximately 73% of our consolidated revenues.”
FILING10-K0001140361-26-006815cik 0001368514
“Effective October 1, 2024, we entered into an Amended and Restated Plasma Purchase Agreement with Grifols (the "A&R Grifols Agreement") with a term expiring in September 2039, after which it may be renewed for two additional multi-year periods if agreed to by the parties.”
FILING10-K0001140361-26-006815cik 0001368514
“Effective August 6, 2024, we entered into a Plasma Purchase Agreement with KEDPlasma LLC ("KEDPlasma") with a term expiring in July 2031, after which it may be renewed for an additional multi-year period if agreed to by the parties (the "KEDPlasma Agreement").”
FILING10-K0001140361-26-006815cik 0001368514
“* Pursuant to a shared services agreement, as amended, with Areth, LLC ("Areth") for office, warehouse space and related services pursuant to which the Company pays Areth monthly lease payments of $10,000.”
FILING10-K0001140361-25-009257cik 0001368514
“Pursuant to our Manufacturing, Supply and License Agreement effective as of December 2012, we granted to Biotest AG ("Biotest") an exclusive license to market and sell ASCENIV in Europe and in certain countries in Northern Africa and the Middle East (the "Territory"), to have access to our testing services for testing of Biotest's plasma samples using our proprietary RSV assay, and to reference (but not access) our proprietary information for the purpose of Biotest seeking regulatory approval for ASCENIV in the Territory.”
FILING10-K0001140361-26-006815cik 0001368514
“Our senior secured credit facility with JPMorgan Chase Bank, N.A. and certain other lenders party thereto (collectively "JPMorgan") is subject to acceleration in specified circumstances, which may result in JPMorgan taking possession and disposing of any collateral.”
FILING10-K0001140361-26-006815cik 0001368514
Watchlist prices, news filtered to it, and its next report on your desk.
ADMA (Adma Biologics, Inc.) has 4 disclosed suppliers and 4 disclosed customers, strongest disclosure first.
Suppliers:
Customers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.
Largest move on the map today: GRFS −1.40%, in industrials & materials.